Latest: FDA Approves New Biosimilar for Oncology Treatment

Health Canada Approves Pembrolizumab/Surgery in Locally Advanced HNSCC

by Cancer Network

14 September, 2025

0 Mins

Results from the phase 3 KEYNOTE-689 trial supported the agency’s approval of the pembrolizumab/surgery regimen in PD-L1–positive head and neck cancer.

Tags:

Author

Cancer Network

Overviewing 36-Month, Phase 1b Data Testing Gene Therapy AB-1005 in Parkinson Disease: Nisha Chhabria MD, FAAN

Draft of major MAHA report calls for more education, less regulation — and offers few policies

📢

300x250 Banner

Health Canada Approves Pembrolizumab/Surgery in Locally Advanced HNSCC

Tags:

Cancer Network

Overviewing 36-Month, Phase 1b Data Testing Gene Therapy AB-1005 in Parkinson Disease: Nisha Chhabria MD, FAAN

Draft of major MAHA report calls for more education, less regulation — and offers few policies

Recent Content

COPD Biologics: Early Treatment Insights

Antihypertensive Medication Guidelines

Juvenile Arthritis Care Transition